MES V 180 Pill - yellow capsule/oblong, 19mm
Pill with imprint MES V 180 is Yellow, Capsule/Oblong and has been identified as Pyridostigmine Bromide Extended-Release 180 mg. It is supplied by Oceanside Pharmaceuticals.
Pyridostigmine is used in the treatment of Myasthenia Gravis; Nerve Agent Pretreatment; Reversal of Nondepolarizing Muscle Relaxants and belongs to the drug class cholinergic muscle stimulants. Risk cannot be ruled out during pregnancy. Pyridostigmine 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MES V 180
Pyridostigmine Bromide Extended-Release
- Imprint
- MES V 180
- Strength
- 180 mg
- Color
- Yellow
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Cholinergic muscle stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Oceanside Pharmaceuticals
- Inactive Ingredients
-
carnauba wax,
zein,
magnesium stearate,
silicon dioxide,
tricalcium phosphate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 68682-0301 (Discontinued) | Oceanside Pharmaceuticals, Inc. |
| 00187-3013 | Bausch Health Companies Inc. |
Related images for "MES V 180"
More about pyridostigmine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (56)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: cholinergic muscle stimulants
- Breastfeeding
- En español
Patient resources
- Pyridostigmine drug information
- Pyridostigmine Extended-Release Tablets
- Pyridostigmine Tablets
- Pyridostigmine Injection
- Pyridostigmine Liquid
Other brands
Professional resources
- Pyridostigmine monograph
- Pyridostigmine (FDA)
- Pyridostigmine Bromide Oral Solution (FDA)
- Pyridostigmine Bromide Solution (FDA)
- Pyridostigmine ER tablets (FDA)
- Pyridostigmine Oral Solution (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
